Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 808 results for "epo"

World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin...

Research and Markets (http://www.researchandmarkets.com/research/5qb5x5/the_world_market) has announced the addition of the "The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)" report to their ... Individual.com, 3 days ago
[x]  

175 images for epo

Rochester City Newspaper, 2 days ago
Presse Box, 1 week ago
Presse Box, 1 week ago
Presse Box, 1 week ago
Presse Box, 1 week ago
JD Supra, 3 days ago
Retail Technology, 4 days ago
Retail Technology, 1 week ago
ArticleSnatch.com, 1 week ago
Managing IP, 3 weeks ago
European Patent Office

Shaking things up - guide to recent EPO changes of procedure

There has been a fair amount of procedural change at the European Patent Office (EPO) recently. As a guide for applicants, here we summarise ten of these changes: Druckexemplar (text intended for grant) produced electronically From 01 April 2014. ...
 Lexology4 days ago Patent filings at the EPO in 2013 - Finland among the top three  Noodls5 days ago European Patent Office: EPO filing record  Managing IP2 weeks ago EPO chief: It takes time before patent filings lead to growth and job creation  EurActiv.com4 weeks ago
[x]  

EPO fees - appeal and divisional fees now in effect

Inflation adjusted EPO fees will increase by an average of about 4.3%, although the European Search Fee will rise by about 10.3% (to EUR 1285) in order to bring it more into line with the cost of an International Search carried out by the EPO as ...
 Lexology4 days ago Supplementary publication 3 OJ is now available  European Patent Office2 weeks ago

EPO Upholds Alnylam's McSwiggen Patent

The European Patent Office ( EPO.V ) has upheld Alnylam Pharmaceuticals, Inc. 's ( ALNY ) McSwiggen EP 1423406 ('406) patent in oral opposition proceedings in Germany. Alnylam's shares gained around 3.9% following the news. We note that the ...
 Yahoo! Finance1 week ago
[x]  

DESTINY MEDIA : TECHNOLOGIES INC Other Events (form 8-K)

03/21/2014 | 06:04am US/Eastern Recommend: 0 ITEM 8.01 Other Events. The European Patent Office (EPO) issued an official communication under Rule 71(3) of the European Patent Convention indicating that it intends to grant Destiny ...
 4 Traders4 weeks ago European office upholds 3G patent disputed by Nokia, HTC, Apple  Business Standard2 months ago The Official Journal 3/2014 is now available online  European Patent Office2 weeks ago
JD Supra

Early Assignment of your Invention as a Method to Maintain Priority Rights in a European Patent Application

The European Patent Office (EPO) has been a desirable venue for seeking patent protection in Europe. For instance, a patent application granted by the EPO can provide patent protection in many European countries, such as the United Kingdom, France, ...
 JD Supra3 days ago EPO not aware of future demonstrations  World Intellectual Property Review2 weeks ago Unified Patent Court: Harmonising Patent Law Throughout Europe?  International Bar Association3 weeks ago Guide To Formal Requirements of the EPO - A Course for Administrative Staff in the Patent Profession (London)  TickerTech.com4 weeks ago
[x]  
Scottrade

Encanto Potash and Muskowekwan First Nation Report on Successful Surface Designation Vote

TRADING SYMBOL: TSXV:EPO VANCOUVER, April 16, 2014 /CNW/ - Encanto Potash Corp . ("Encanto" or the "Company") (TSXV: EPO and OTCQX: ENCTF) is pleased to announce all six ballots for the Muskowekwan First Nation ("MFN") Surface Designation vote ...
 Scottrade2 days ago Encanto Potash Corp. (ENCTF: OTCQX International) | Encanto Potash and Muskowekwan First Nation Report on Successful Surface Designation Vote  Pink Sheets2 days ago ENCANTO POTASH : and Muskowekwan First Nation Report on Successful Surface Designation Vote  4 Traders2 days ago Encanto announces closing of $3.65 million prospectus offering  OSIX News3 days ago
[x]  

BIOPORTO A/S : EPO rules BioPorto's NGAL cutoff-patent invalid

Today, the European Patent Office (EPO) has decided that BioPorto's NGAL cutoff patent no. EP1831699 does not meet the requirements for adequate description. The patent is thus ruled invalid. In BioPorto's assessment, the company still has a very ...
 4 Traders2 weeks ago EPO rules BioPorto's NGAL cutoff-patent invalid  Noodls2 weeks ago
American Banking News

Plays update: Earthport

EARTHPORT (EPO:AIM)38.75p Gain to date: 61.5% Two significant contract wins in the space of a week leave cross-border payments operator Earthport (EPO:AIM) trading at a record high of 38.75p. Last week (19 Mar) the £149 million
 Shares Magazine3 weeks ago Earthport Wins Contract With PNC Bank, Fee Not Disclosed  ADVFN India3 weeks ago Earthport Stock Rating Reaffirmed by Panmure Gordon (EPO)  American Banking News1 month ago

Court of Appeal stays appeal proceedings pending outcome of central amendment applications to the EPO

By Laura von Hertzen On 11 March 2014, in a patent action between Samsung and Apple, the Court of Appeal of England and Wales granted Samsung an application to adjourn an appeal from the High Court's decision that two of Samsung's patents were ...
 The Lawyer1 day ago I want you to stay: Court of Appeal agrees to await outcome of EPO central limitation  Intellectual Asset Management3 weeks ago Samsung v Apple and the EPO  SCL.org1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - epo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less